Upexi (NASDAQ:UPXI – Get Rating) and Exactus (OTCMKTS:EXDI – Get Rating) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.
Profitability
This table compares Upexi and Exactus' net margins, return on equity and return on assets.
Get
Upexi alerts:
| Net Margins | Return on Equity | Return on Assets |
| Upexi | -9.97% | -13.93% | -9.55% |
| Exactus | N/A | -3,272.69% | -185.29% |
Analyst Ratings
This is a summary of current ratings and price targets for Upexi and Exactus, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Upexi | 0 | 0 | 1 | 0 | 3.00 |
| Exactus | 0 | 0 | 0 | 0 | N/A |
Upexi currently has a consensus target price of $7.00, suggesting a potential upside of 125.81%. Given Upexi's higher probable upside, analysts clearly believe Upexi is more favorable than Exactus.
Institutional and Insider Ownership
3.1% of Upexi shares are owned by institutional investors. Comparatively, 0.1% of Exactus shares are owned by institutional investors. 55.0% of Upexi shares are owned by insiders. Comparatively, 65.0% of Exactus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Risk & Volatility
Upexi has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Exactus has a beta of 4.21, meaning that its stock price is 321% more volatile than the S&P 500.
Earnings & Valuation
This table compares Upexi and Exactus' gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Upexi | $44.58 million | 1.16 | -$2.10 million | N/A | N/A |
| Exactus | $2.07 million | 28.07 | -$9.46 million | N/A | N/A |
Upexi has higher revenue and earnings than Exactus.
Summary
Upexi beats Exactus on 7 of the 11 factors compared between the two stocks.
About Upexi
(Get Rating)
Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.
About Exactus
(Get Rating)
Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.
